Cleared Traditional

imani i2 (K202037) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202037 · Imani Co. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
221d
Days
Class 2
Risk

K202037 is an FDA 510(k) clearance for the imani i2. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.

Submitted by Imani Co. (Yongin-Si, KR). The FDA issued a Cleared decision on March 1, 2021 after a review of 221 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Imani Co. devices

Submission Details

510(k) Number K202037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2020
Decision Date March 01, 2021
Days to Decision 221 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 160d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HGX Pump, Breast, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Global Medical Standard Consulting Co., Ltd.
Do Gyun Lim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HGX Pump, Breast, Powered

All 127
Devices cleared under the same product code (HGX) and FDA review panel - the closest regulatory comparables to K202037.
Electric Breast Pump
K201152 · Guangdong Horigen Mother & Baby Products Co., Ltd. · May 2021
Mya Joy PLUS Breast Pump
K203570 · Ameda, Inc. · Apr 2021
Electric breast pump (Models: RH-228 and RH-338)
K201903 · Cixi Ruihong Electric Appliance Co., Ltd. · Apr 2021
imani i1
K202045 · Imani Co. · Feb 2021
Hi bebe super (Models BT-150S and BT-150L)
K200675 · Bistos Co., Ltd. · Feb 2021
Philips Avent Double electric breast pump Advanced SCF394/61, Philips Avent Double electric breast pump Advanced SCF394/62
K203383 · Philips Consumer Lifestyle - Innovation Site Eindhoven · Dec 2020